MorphoSys Investments

MorphoSys has invested in 1 company and its latest investment was Adivo on Aug 19, 2018

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Adivo specializes in developing species-specific therapeutic antibodies for pet cancer and chronic inflammatory conditions.
-
Aug 19, 2018
-